A child with HIV takes a paediatric dose of antiretroviral medication. Many paediatric HIV trials were conducted in South Africa over the past 20 years.

Essential research on tuberculosis and HIV cancelled. Clinical trial participants in limbo. Young researchers’ careers halted  – and billions of dollars invested and expertise developed over 30 years potentially down the drain.

These are some of the impacts on South Africa of the decision by the National Institutes of Health (NIH) barely a week ago to prohibit United States scientists from working with foreign researchers via “subawards”, leading to the immediate and mass cancellation of such grants with South African institutions.

At least 39 TB and HIV clinical research sites in South Africa are under threat due to NIH funding cuts, jeopardising at least 27 HIV trials and 20 TB trials, according to an analysis by the Treatment Action Group (TAG) and Médecins Sans Frontières (MSF) drawn mostly from the NIH’s Division of AIDS (DAIDS) presented at a media briefing on Thursday.

Impact of NIH cuts on TB and HIV research in South Africa

TB trials at risk include testing potential vaccines and new drugs; shorter, safer regimens, and the best treatment for TB meningitis. 

The HIV trials at risk include cure-related treatments involving broadly neutralising antibodies (bNAbs); vaccines designed to prime the body to make bNAbs; the impact of hormone treatment on women with HIV and treatment options for pre-exposure prophylaxis to prevent HIV.

Many of these trials are global, with South Africans making up 30-50% of global trial participants and 50-90% of trials on interventions for children and pregnant women, said Lindsay McKenna, TAG’s TB project co-director.

She estimates that the average investment in each trial participant is $12,000 – potentially all wasted if the trials are discontinued.

For some 30 years, South African clinical studies have provided global guidance on issues including prevention of mother-to-child HIV infection, when to start children on antiretroviral treatment, how to simultaneously treat TB and HIV, as well as the safety of HIV and TB treatments. Meanwhile, operational research, such task-shifting from HIV doctors to nurses, has led to more efficiency and cost-cutting.

“NIH funding is not aid. It’s competitive funding that researchers here competed for that went through stringent NIH processes and committees,” stresses Marcus Low, an epidemiologist and editor.

The NIH cuts come on top of the cancellation of grants from the US Agency for International Development (USAID) and US Centers for Disease Control (CDC) – primarily for HIV and TB programmes.

Impact on institutions

“South African academic and research institutes could lose about 30% of their annual income and may be forced to lay off hundreds of staff as a result of US funding cuts,” the analysis notes.

It warns of “the potential collapse of TB and HIV research and development capacity” in the country, with global impact in light of “ the substantial contributions of South African research centres to advancements in TB and HIV prevention, treatment, and care worldwide.”

(From Top L-R) Lindsay McKenna, Ian Sanne, Tom Ellman, (Bottom L-R) Marcus Low, Ntobeko Ntusi and Linda-Gail Bekker
(Top L-R) Lindsay McKenna, Ian Sanne, Tom Ellman, (Bottom L-R) Marcus Low, Ntobeko Ntusi and Linda-Gail Bekker

Professor Ntobeko Ntusi, head of the South African Medical Research Council (SAMRC), told the media briefing that the country had been disproportionately affected both because of its high burden of HIV and TB and the excellence of its scientific community – making it a preferred site for research.

“Universities are now beginning retrenchments at scale,” said Ntusi, adding that affected scientists also provide postgraduate training.

“Hundreds of master’s, doctoral and post-doctoral fellows, whose stipends and research costs are dependent on these grants, find themselves in a position of inordinate precarity,” said Ntusi.

‘Ethical nightmare’

Prof Ian Sanne, co-principal investigator of the Wits HIV Research Group Clinical Trials Unit, describes navigating the US funding cuts as a “major regulatory and ethics nightmare”.

NIH investment in South African HIV and TB research “amounts to almost $2 billion over 20 years”, according to Sanne. His institution alone, Wits University in Johannesburg, stands to lose $150 million to $180 million in NIH funding.

As co-chair of Wits University’s ethics committee, Sanne has had to work with units on contingency plans for both staff and trial participants – despite US funds being terminated with immediate effect with nothing left over to wind down processes.

“In one of the studies in KwaZulu-Natal, the sponsor, USAID, stopped funding overnight and the microbicide rings that were under research with the participants were terminated without their knowledge,” said Sanne, leading to “a real ethical problem”.

Microbicide rings impregnated with ARVs are inserted vaginally to prevent HIV and studies often involve sex workers with high risk of HIV infection.

Sanne’s unit lost US funding with immediate effect on 21 March – but it then had to embark on retrenchment procedures in terms of South African law, draining the reserves of the unit.

Expertise and infrastructure lost

Prof Linda-Gail Bekker, director of the Desmond Tutu HIV Centre at the University of Cape Town, says her centre will lose $6.9 million out of $10 million in NIH funds.

Earlier in the year, the centre lost a HIV vaccine grant worth $45 million over five years from USAID that would have seen five trials in eight southern African countries “contributing to the global quest to find an effective HIV vaccine”, she added.

The centre employs 400 people and will have to retrench “one-third to half our workforce”, said Bekker, whose groundbreaking research on a twice-yearly injection to prevent HIV infection earned her a standing ovation at the International AIDS Conference in Munch last year.

Professor Linda-Gail Bekker presenting the results of the PURPOSE 1 trial at the Munich AIDS conference, which found a twice-a-year injectable ARV prevented all women in the trial from contracting HIV.

“We have an incredible critical mass of very experienced and very well-established research organisations in the country, and the infrastructure that has been built over the last 30 years has established an extraordinary clinical trial infrastructure,” said Bekker.

South Africa was able to use this expertise and infrastructure during the COVID-19 pandemic to “pivot to test at great speed, new COVID-related vaccines”.

“Throughout the years, we have contributed to creating new knowledge that is often [Investigational New Drug] related studies… that feeds into important guidance, such as the WHO guidance. 

Impact on other African countries

Dr Tom Ellman, director of MSF’s Southern Africa Medical Unit, said that MSF has applied the “pragmatic” HIV and TB research generated in South Africa in resource-poor settings throughout the continent.

Recently back from the Democratic Republic of Congo (DRC), Ellman said it was able to draw on the “self-managed, fixed-combination antiretroviral treatment regimen” developed in South Africa for people living with HIV in the conflict zone in South Kivu.

MSF’s large HIV programme in Kinshasa relies on dolutegravir – “a basic, simple, effective drug enabled by South African research”, said Ellman, who listed several other drugs that had been trialled in South Africa before hitting the global market.

“The best science leads to impact in the most difficult settings. There’s no question that South African science has transformed access to HIV, TB and other disease responses across Africa and across the world.”

Ellman said the funds cut is “particularly awful”  as “we are closer than ever to finding ways out of the HIV, TB and malaria pandemics”.

Appeal for support

TAG, MSF and the SAMRC have appealed for “alternative funds to sustain TB and HIV research in South Africa”.

Ntusi says numerous donors and governments have offered support and solidarity – but most wish to remain anonymous at present.

The researchers all agreed that the most urgent need is to provide immediate support to clinical research sites to ensure continuity of care and follow-up for study participants. 

“South African trial participants must be supported to complete treatments safely and, in cases of treatment failure, be offered appropriate alternatives, and research sites must be supported to complete data collection and analysis,” said TAG and MSF.

Image Credits: Paul Kamau/ DNDi, IAS.

A nurse tests a patient for hypertension. Two-thirds of Africans with high blood pressure are unaware of their condition.

Three key issues feature in the United Nations zero draft of the political declaration on non-communicable diseases (NCDs) and mental health, published on Thursday in preparation for the High-Level Meeting on 25 September.

Tobacco control, hypertension and improving mental health care are the cornerstones of proposed action to contain NCDs. The draft proposes 2030 global targets of 150 million fewer people using tobacco, 150 million more people controlling their hypertension and 150 million more people having access to mental health care.

Five sub-targets are included in the 10-page draft as the pathway to achieving the three “150 million” targets by 2030.

The first focuses on at least 80% member states countries implementing excise taxes on tobacco, alcohol, and sugar-sweetened beverages at levels recommended by the World Health Organization (WHO).

The second is for 80% of public primary health care facilities in all countries to have “uninterrupted availability” of at least 80% of World Health Organization-recommended essential medicines and basic technologies for NCDs and  mental health conditions at affordable prices by 2030.

Other targets relate to limiting the cost of essential NCD and mental health “services, diagnostics, and medicines”, integrated country-based frameworks and surveillance and monitoring.

Member states have a tight window – until 27 May – to submit written comments on the draft ahead of the first round of negotiations on 5 June. 

No mention of fossil fuel

The NCD Alliance (NCDA), which has been leading civil society mobilisation ahead of the HLM, told Health Policy Watch that it is currently studying the draft and will formulate its response early next week, and will share its analysis at a public webinar on 20 May.

However, an NCDA advocacy briefing outlines its key asks, including universal health coverage (UHC) and achieving the Sustainable Development Goal (SDG) target on NCDs. 

Seventy percent of deaths are caused by NCDs, as unhealthy diets, lack of exercise, smoking, air pollution, and poor mental health take their toll globally. Yet only 19 countries are on track to achieve SDG 3.4 to reduce premature mortality from NCDs by one-third by 2030.

Several of the NCDA asks are in the draft, but perhaps not as strongly stated as it would like.

For instance, while the draft identifies the need to reduce air pollution – the second biggest driver of NCD deaths after tobacco –  there is no mention of the cutting back on fossil fuel use.

The draft proposes that a reduction in air pollution can be achieved through clean urban transport, reducing burning of agricultural residue, and access to “affordable and less polluting fuels for cooking, heating and lighting”.

The NCDA wants interventions to “reduce air pollution and fossil fuel use” – and for government policies to be protected from the influence of the fossil fuel industry. 

The draft’s only reference to climate change is its acknowledgement that countries’ resources are strained by several emergencies including “climate crises” – whereas the NCDA wants policies to cost health and climate, reduce fossil fuel use, and ensure funding for vulnerable countries, particularly Small Island Developing States (SIDS). (The draft does acknowledge the “unique vulnerabilities” for people living in SIDS.)

Increased funding

“The last decade has been coined as a policy success, but an implementation failure. This HLM has to change this, renewing commitments to cost-effective policies that we know work to reduce the risk factors and improve access to care,” Katie Dain, NCDA CEO, told a recent multi-stakeholder hearing called by the UN Secretary General ahead of the HLM.

Dain added that the HLM “must address the glaring mismatch between the scale of the burden of NCDs and the level of funding”.

“We urge governments to increase sustainable financing for NCDs by adopting specific and measurable financing targets for NCDs and improving financing data and tracking, as well as committing to health taxes that have a triple win of raising revenue, improving health outcomes and reducing long-term healthcare costs.”

The draft devotes five points to increased budgets, which call for increased domestic resources (helped by funding from the excise taxes), more donor resources and strategies such as pooled procurement for medicines.

It also calls on countries to “urgently scale up the percentage of public health budgets dedicated to mental health with the aim to increase the current global average of 2% to at least 5% by 2030”.

Human rights approach

Importantly, the draft stresses the importance of adopting a human rights-based approach, acknowledging that people living with NCDs and mental health issues are “routinely and unjustly deprived of such access and discriminated against”.

It also calls for measures to decriminalise suicide, which was a key demand made by civil society groups at the recent multi-stakeholder hearing.

Image Credits: Hush Naidoo Jade Photography/ Unsplash.

Jubilant and exhausted members of the Intergovernmental Negotiating Body (INB) pose after marathon pandemic agreement talks finally resulted in agreement in the early hours of 16 April.

The final draft of the pandemic agreement for the World Health Assembly (WHA) next week was published by the World Health Organization (WHO) on Wednesday – along with a document outlining the long road member states still have to travel before it is enforced.

This follows the historic agreement reached on the text in the early hours of 16 April after three years of talks on how to prevent, prepare for, and deal with, future pandemics in an equitable manner – unlike what happened during COVID when wealthy nations hoarded vaccines at the expense of low- and middle-income countries.

The procedural document outlining the steps to adoption, which will be done in terms of Article 19 of the WHO Constitution, makes sobering reading.

While the agreement needs a two-thirds vote to pass, “adoption of the text by consensus automatically fulfils this requirement”, it notes.

Once the WHA has adopted the agreement via a resolution, it will be deposited with the Secretary-General of the United Nations, who will ensure it is prepared in various languages for signature.

Member states are expected to notify the WHO Director General on whether they intend to accept the agreement within 18 months of its adoption by the WHA.

Still more PABS negotiations

But member states’ signature of the pandemic agreement will only happen after the adoption of an annex on the much-contested Pathogen Access and Benefit-Sharing (PABS) System – a mechanism on how to share information about pathogens with pandemic potential and any possible benefits (such as vaccines and therapeutics) that might arise from sharing this information.

This annex – called the PABS instrument – still has to be negotiated, and it deals with a range of issues including “the provisions governing the PABS System, definitions of pathogens with pandemic potential and PABS Materials and Sequence Information, modalities, legal nature, terms and conditions, and operational dimensions”.

This means the PABS can of worms will be reopened in the coming months and member states will once again have to find agreement on this highly contested subject.

Only once the annex has been agreed, will the WHO Pandemic Agreement be open for signature by heads of state.

But even once the heads of state have signed the agreement, countries are not bound by its provisions. 

Instead, by signing, a head of state would be “expressing political approval of the treaty concerned, and raises an expectation that the signatory will in due course take the appropriate domestic actions to become a contracting party”. 

However, before domestic ratification, member states that have signed the treaty will be expected not to undermine the agreement.

Countries that have ratified the pandemic agreement will then be expected to deposit instruments of ratification with the UN Secretary-General and once 60 countries have done so, it will come into force and the first Conference of Parties will be held.

The entire process is likely to take several years, during which time another pandemic can engulf the world.

The Pandemic Agreement still has to pass through several hoops, including more negotiations on a PABS System, before it comes into force.

 

Image Credits: Thiru Balasubramaniam.

In the shakeup, only four members of WHO’s existing senior leadership team remain: Farrar, Ihekweazu, Nakatani and Pendse.

A brand-new World Health Organization (WHO) leadership team has been announced, including a dramatically reduced number of leaders and a major shake-out of longstanding faces including Dr Mike Ryan, the Deputy Director General and emergencies director, and Dr Bruce Aylward, who helped the Director-General steer the organization through the COVID-19 crisis but also got the heat for some of the mistakes made by the organization in the process.

In Ryan’s place, Dr Chikwe Ihekweazu, a Nigerian-German who is currently head of Health Emergency Intellience and Surveillance at a WHO pandemic hub in Berlin, will take over as head of the entire health emergencies operation at headquarters, the largest department in the organization, Health Policy Watch learned from an internal email sent by DG Dr Tedros Adhanom Ghebreyesus to staff Wednesday morning.

A formal WHO announcement followed shortly afterwards during remarks by Tedros at the opening meeting of the Programme Budget and Adminstration Committee (PBAC), a member state group convening ahead of next week’s World Health Assembly.

Dr Jeremy Farrar, a well-respected British scientist and former head of Wellcome Trust, will take on the second biggest appointment as Assistant Director-General (ADG) of Health Promotion, Disease Prevention and Control – one of the major pillars of the new organization – which will consolidate the 10 existing divisions into four.

New WHO organizational plan, announced 22 April, reduces 10 divisions at headquarters to just four.

Farrar will be replaced as Chief Scientist by Dr Sylvie Briand, former director of WHO’s Epidemic and Pandemic Preparedness and Prevention Department and current director of the Global Pandemic Preparedness and Monitoring Board, an independent body co-convened by the WHO and the World Bank to ensure preparedness for global health crises.

Sylvie Briand, far right, to become WHO Chief Scientist.

Japanese national Dr Yukiko Nakatani will remain on the team as head of the third new programme division, ADG of,Health Systems.

Raul Thomas, of Trinidad and Tobago, will remain as WHO’s ADG of Business operations along with Razia Pendse, an Indian national, as the ‘Chef du Cabinet.’

In his announcement to staff, Tedros said that the appointments would take effect on 16 June. Speaking shortly afterwards to the PBAC, he added, “The new team has been chosen after very careful consideration, and to ensure gender balance and geographical representation.

“I am confident that this new team, under the restructured organization, is best positioned to now guide WHO as we face the challenges of the coming years.”

Early reactions to new team

Dr Tedros Adhanom Ghebreyesus on 10 April – facing tough budget cuts.

Very initial reactions from staff inside the organization and outsiders seemed to be positive.

“It was a difficult decision for the DG, because he had to ensure, gender, geographical equity, and that donors priorities were also met,” said one long-time WHO insider, “but overall it seems like a good balance,” noting that most of the new appointees have solid professional reputations.

The sweep out of old leadership long associated with Tedros’ tenure may help improve the organization’s image and help press “reset” for further changes, the source added.

Notably, there is neither a Chinese nor an American in the new leadership team – reflecting perhaps an attempt to sidestep the fraught geopolitical tensions that have plagued the organization since COVID.

Along with Ryan, Aylward, ADG for Universal Health Coverage, who served WHO for 30 years, including leadership of its Global Polio Eradication initiative and the WHO Emergencies Programme, is also gone. Aylward, a Canadian physician, also led some of the Organization’s early response to the COVID pandemic. Although rightly or wrongly, Aylward, like Tedros and other senior WHO leadership, also later came under fire for being too deferential to China, or even praising China’s handling of the outbeak in its early days – as the crisis swept across the world, paralyzing travel and shutting down economies.

Farrar, meanwhile, has emerged as an even more senior figure in the agency shake-up and someone to watch for the future.

Briand, a French national, as head of research offers the WHO the opportunity to strengthen its organizational links to European research institutions at a time when the United States is cutting funding for science research and innovation both at home and abroad.

“In that context, it’s historic to see a French national become head of research,” said one WHO scientist.

WHO Organization as of January 2025 boasted 10 divisions and 76 department directors.

The new team now faces the big challenge of reducing the number of WHO directors at headquarters by more than half, in line with a plan to dramatically cut WHO’s budget in the face of the loss of funds due to the US withdrawal, WHO’s largest donor, from the agency, announced by new US President Donald Trump in January.

Facing a $600 million shortfall in 2025 and a $1.7 billion funding gap for the 2026-27 biennium, according to the latest estimates, the WHO reorganisation would cut the number of departments at headquarters by nearly half – from 76 department directors as of January 2025 to around 34 departments and directors, according to the new organogram.

The number of directors at headquarters would be slashed by more than half, from 76  to 34, according to Tedros, speaking to PBAC.

“Decisions about which directors will lead which departments will be made following the World Health Assembly. That, I know, will also be tough, given the downsizing from 76 to 34 departments,” Tedros said in his message to PBAC members.

“I emphasize that our focus on strengthening our country offices is unchanged, although we do plan to close some offices in high-income countries that no longer need in-country support.”

Options for programme relocation outside of Geneva HQ

Illustrative options for WHO programme relocation to less-expensive settings in Europe and Africa, presented to the member state Planning, Budget and Administration (PBAC) meeting today.

At the closed-door PBAC meeting, Tedros also provided member states with an initial review of possibilites for relocating certain WHO departments and teams now based in Geneva to other existing WHO or UN hubs in more affordable locations – in Europe as well as Africa, Health Policy Watch learned.

Such “illustrative” options include: the relocation of certain health workforce teams to Lyon, two hours from Geneva in nearby France; moving more health emergency functions to Berlin, where WHO already has a pandemic surveillance office co-supported by the German government; relocation of IT support to an existing UN hub in Valencia; and finally, relocation of critical WHO infectious disease programmes to South Africa, Nairobi or Addis Ababa. This could bring those programmes “closer to the world regions with heaviest disease burden” alongside other major UN and African policy and research hubs.

Such relocations could help mitigate some of the fallout at headquarters, were as many as 30-40% of WHO’s 2600 rank-and-file staff could reportedly be facing layoffs, based on WHO’s existing budget shortfall there, the biggest  in the organization.

“We anticipate that the most significant staff reductions will be at headquarters, while regional offices will also be affected to varying degrees,” Tedros told PBAC, although he has so far provided no exact projections as to how many would be laid off, saying that will only become clear once a more detailed organizational “prioritization” exercise is completed. Tedros added, however, that WHO already has introduced “a range of support mechanisms, and we are committed to supporting the mental health and well-being of all our colleagues.”

Salary gap by region for 2025 as presented to WHO member states in March, shows more than half of the deficit is in headquarters.

“Now they have to cut down 50% of the directors, so the work is only begun,” one observer said. “”In any case this is a transitional team because the Director-General will complete his term in two years time.”

The retrenchment follows years of expansion during the COVID pandemic, and post-COVID outbreaks and humanitarian crises, when the number of WHO’s most senior directors nearly doubled, along with the ranks of consultants. See related story:

https://healthpolicy-watch.news/exclusive-number-of-who-senior-directors-nearly-doubled-since-2017-costs-approach-100-million/

Image Credits: WHO , WHO, Fletcher/HPW , WHO, 2025, WHO .

Scarcity of food in Gaza is increasingly causing malnutrition and severe hunger as the war continues.

All 2.1 million people in Gaza face hunger and diseases while life-saving supplies sit just beyond the borders, denied entry after nine weeks of a total blockade, Dr Hanan Balkhy, World Health Organization (WHO) regional director for the Eastern Mediterranean, told a media briefing on Tuesday.

“The Israeli authorities propose to shut down the UN-led aid distribution system and deliver aid under conditions set by the military, but WHO and the United Nations will not participate in any initiative that violates humanitarian principles. Aid must reach those in need, wherever they are, and the blockade must end,” she added.

Dr Hanan Balkhy, World Health Organization (WHO) regional director for the Eastern Mediterranean.

The entire population is facing high levels of acute food insecurity, while half a million people (one in five) are facing starvation, according to the Integrated Food Security Phase Classification (IPC) report released on Monday.

Three quarters of Gaza’s population are at “emergency” or “catastrophic” food deprivation, the worst two levels of IPC’s five level scale of food insecurity and nutritional deprivation.

Since the blockade began on 2 March, 57 children have reportedly died from the effects of malnutrition. 

If the situation persists, nearly 71 000 children under the age of five are expected to be acutely malnourished over the next 11 months, according to the IPC report.

Dr Richard Peeperkorn, WHO Representative in the occupied Palestinian territory.

Dr Richard Peeperkorn, WHO Representative in the occupied Palestinian territory, told the media briefing that 70,000 pregnant and lactating women “are expected to require treatment for acute malnutrition”, with their children facing long-term effects including stunted growth and impaired cognitive development.

The United States announced last week that it supported food aid being channelled to Gaza via a private company un by US contractors, the Gaza Humanitarian Foundation. 

The Israeli government has said that it supports the plan, but the UN has described it as “weaponizing aid”.

Peeperkorn said that there needed to be an immediate lifting of the blockade but that aid needs to be delivered via “One UN action” in terms of the “global humanitarian principles of humanity, impartiality, independence and neutrality”.

“There is a well established and proven humanitarian coordination system led by the UN and its partners that is already in place and must be allowed to function fully to ensure that aid is delivered in a timely and equiptable manner,” said Peeperkorn.

He added that discussions are ongoing between the UN, Israel and the US and he hoped this would result in the resumption of aid as the WHO, World Food Programme and UNICEF were all ready with “massive amounts of food, medicine and water and hygiene supplies”.

US President Donald Trump addresses the US-Saudi investment conference

US President Donald Trump arrived in Saudi Arabia on Monday night for a three-day visit to the Middle East focused on economic partnerships.

Addressing a US-Saudi investment forum on Tuesday evening, Trump said that he hoped Saudi Arabia will rejoin the “Abraham Accords”, agreements the US negotiated between Israel and some Arab countries during his first term. However, Saudi Arabia has ruled out normalising relations with Israel while it is at war with Gaza.

On the eve of Trump’s visit, The Guardian reports that his Middle East envoy Steve Witkoff said that the US “want to bring the hostages home, but Israel is not willing to end the war. Israel is prolonging it”.

‘Forgotten crises’

Yemen is also facing one of the world’s largest cholera outbreaks with over 270,000 suspected cases and 900 deaths in the past year, said Dr Ahmed Zouiten, acting regional emergency director for WHO EMRO.

Some 19.6 million people in Yemen are in need of humanitarian aid after 10 years of war.

Recent escalation in violence has threatened the country’s main port and airport, key gateways for humanitarian aid.

WHO only received 8% of $56 million funding it needs to address the crisis in Yemen.

“We need to secure further funding as soon as possible otherwise one mother and six newborns will continue to die every two hours already,” said Zouiten.

Meanwhile, Sudan is facing the world’s worst hunger crisis in terms of scale,with  an estimated 24.6 million people facing food insecurity this month, including 770,000 children suffering from severe acute malnutrition, said Balkhy.

“Some 8.2 million people are losing or at risk of losing access to health because of the shrinking funding for WHO and the health cluster partners. So we need support in Yemen. We need support in other forgotten crisis – Afghanistan and Pakistan, Syria and Somalia.”

Image Credits: WHO.

A young boy with type 1 diabetes gets his blood glucose level tested. Such non-invasive tests aren’t readily available in many countries.

Access to insulin remains elusive and expensive for many children and young people (CYP) living with type 1 diabetes (T1D) in low- and middle-income countries (LMICs), according to a report released Tuesday by the Access to Medicine Foundation.

The report evaluates 11 company-supported initiatives targeting children and young people by the market’s three dominant insulin producers – Lilly, Sanofi, and Novo Nordisk – and biosimilar manufacturer Biocon.

All four companies donate “vital” products or funding for insulin in 71 of 113 LMICs covered by the report, but as these are sustained by donations, “long-term, affordable diabetes care remains a critical challenge”, according to the foundation.

“While these contributions are meaningful and vital to the success of the initiatives, the heavy reliance on donations from industry partners creates a long-term uncertainty,” says the report.

“The lives of CYP depend on these initiatives, and any reduction or withdrawal of support could result in a sudden loss of access to critical products for hundreds of thousands of CYP.”

Ten of the 11 initiatives have set end dates or specific goals, with several scheduled to conclude by or before 2030, which “underscores the uncertainty of sustained access”. 

 “Hundreds of thousands of children and young people in low- and middle-income countries face significant barriers to accessing essential insulin, supplies and care for managing type 1 diabetes. While the pharmaceutical industry is engaged in the effort to bridge access gaps, as needs grow, initiatives must prioritise widespread coverage, sustainability and affordability to save lives, says Claudia Martínez, the foundation’s research director.

High cost of insulin

While Lilly and Novo Nordisk are adapting their models to “better align with local needs and are collaborating with partners to transition T1D care towards government ownership”, it won’t be possible to scale up access if the cost of insulin is not addressed, the report asserts.

For many children, the 11 industry initiatives remain their only way to access treatment, but in 2023, these collectively reached only about 8% of the estimated 825,000 children and youth in need across the 71 countries covered. 

Given that a significant proportion of diabetes in LMICs remains undiagnosed, it is highly likely that this represents an even smaller portion of young people who need access to insulin. 

“The public sector does cover the cost of insulin in some LMICs – either directly or through reimbursement. However, approximately 34% of people in LMICs still pay out of pocket for healthcare, and in many African nations, individuals cover the full costs themselves,” the report notes.

“The need for support remains overwhelming, and for those who are unable to access initiatives, access to the lifesaving care they need remains out of reach.”

A small percentage of initiatives in LMICs have evolved from providing insulin in vials for injection to insulin analogues and insulin pens, which are easier to administer to children and widely accessible in wealthier countries. There is also a lack of access to diabetes monitoring tools 

Some initiatives also include education and training. Seven support training for healthcare professionals to tackle the high rates of misdiagnosis and undiagnosed T1D in LMICs, while Lilly and Novo Nordisk also support investments in infrastructure and equipment.

“Sanofi’s KiDS stands out as the only programme educating not just children and families, but also teachers and school staff,” according to the report.

Solutions

The pharmaceutical companies can scale up access and reach by ensuring that the diabetes treatments and technologies best suited to children are available where they are needed most, moving away from the donation-based models, and addressing affordability and product availability to facilitate the successful transition to government-owned type 1 diabetes care in LMICs, the report concludes.

“This way, all CYP, regardless of where they live, can have access to lifesaving diabetes care products.”

Image Credits: UC Davis health.

Fatmata Bamorie Turay (left) and Elizabeth Tumoe, registered nurses look after newborns at the Princess Christian Maternity Hospital in Freetown Sierra Leone

Although the international nurse workforce has increased by about two million between 2018 and 2023, there is still a huge global shortage concentrated in poorer nations, according to the State of the World’s Nursing 2025 report published on Monday.

There was a global shortage of around 5.8 million nurses in 2023, an improvement on 2018 when there was a 6.2 million shortage, but the shortage is felt most acutely in low-and middle-income countries (LMICs).

Close to half (46%) of all 29.8 million nurses globally are concentrated in high-income countries (HICs), which represent only 17% of the population, according to the report.

The shortage of nurses is felt most acutely in poor countries, particularly in Africa and South East Asia.

LMICs face “challenges in graduating, employing and retaining nurses in the health system” and need to raise domestic investments to create and sustain nursing jobs, according to the report, which was compiled by the World Health Organization (WHO) and the International Council of Nurses (ICN).

Meanwhile, HICs need to “manage high levels of retiring nurses and review their reliance on foreign-trained nurses, strengthening bilateral agreements with the countries they recruit from”, it adds.

In 20 mostly high-income countries, retirements are expected to outpace new entrants, which raises “concerns about nurse shortfalls, and having fewer experienced nurses to mentor early career nurses”.

Migration is depleting fragile workforces

Almost a quarter (23%) of nurses in high-income countries are foreign-born, in contrast to upper-middle-income countries (8%), lower-middle-income countries (1%), and low-income countries (3%).

“When wealthy countries recruit from low-income nations, they risk depleting already-fragile nursing workforces,” warns the ICN, noting that migration is also driven by the under-employment of nurses in low-income countries. 

“The combination of workforce shortages, poor working conditions and compensation, and imbalanced distribution all fuel the vicious cycle of inequitable migration patterns,” notes the ICN.

The report stresses that all countries need to adhere to the WHO Global Code of Practice on the International Recruitment of Health Personnel, and where recruitment from one country to another occurs, there should be “bilateral agreements that translate into mutual and proportional benefits for source countries”.

Although low-income countries are increasing nurse graduate numbers at a faster pace than high-income countries, in many countries, this is “not resulting in improved densities due to the faster pace of population growth and lower employment opportunities”.  

To address this, countries should create jobs to ensure graduates are hired and integrated into the health system and improve working conditions.

“The report clearly exposes the inequalities that are holding back the nursing profession and acting as a barrier to achieving universal health coverage (UHC),” said ICN president Pam Cipriano. 

“Delivering on UHC is dependent on truly recognising the value of nurses and on harnessing the power and influence of nurses to act as catalysts of positive change in our health systems.”

“We cannot ignore the inequalities that mark the global nursing landscape. On International Nurses Day, I urge countries and partners to use this report as a signpost, showing us where we’ve come from, where we are now, and where we need to go – as rapidly as possible,” said WHO Director-General Dr Tedros Adhanom Ghebreyesus.

At a media briefing on Monday, Howard Catton, ICN CEO, said real progress has been made in areas such as “advanced practice nursing, increased Chief Nursing Officer roles, increased graduate preparation of nurses, and reducing outdated gendered associations and attracting more men to the profession”. 

But little progress has been made on “the global health emergency of nursing shortages, hugely worrying indicators of inadequate working conditions and pay, troubling patterns of inequalities and nurse migration, and continued failures to fully enable nurses as leaders working to their full scope of practice and influence”, he added.

Pay and working conditions

Countries that regulate working conditions

The global median entry-level wage of nurses in 2023 was $774 per month in 82 countries, with significant differences by WHO region and by income group. 

Median wages in HICs were twice as high those of upper-middle-income countries, and three times as high LICs. 

Wages adjusted for purchasing power parity indicated that the European and Eastern Mediterranean regions have the highest median entry wages, and the WHO African and South-East Asia regions have the lowest. 

Most countries reported laws on minimum wages (94%), social protection measures (92%) and health worker safety (78%).  But only 55% had regulations on working hours and conditions, and even fewer had provisions for mental well-being.

“Mental health and workforce well-being remain areas of concern. Only 42% of responding countries have provisions for nurses’ mental health support, despite increased workloads and trauma experienced during and since the COVID-19 pandemic,” according to the report.

Policy proposals include empowering nurses to contribute to the climate agenda through education, advocacy, climate-conscious practice in health settings and leadership. 

South East Asian countries had the highest percentage of protections in place (70%) while Western Pacific countries had the lowest (21%). 

By income group, HICs had the most countries (63%) reporting provisions regarding working conditions and hours, while LICs had the fewest (48%). Other sources have described a related pattern in that excessive working hours, defined as working over 48 hours per week, were more frequently reported by nurses and midwives in low- and lower middle-income countries, many in Africa.

Attacks on healthcare workers

An attack on ambulance outside Al-Shifa hospital in Gaza in November 2023.

Measures to prevent attacks on health workers were reported in 59% of the responding countries, representing an increase from the 37% of countries reported on this in 2020. 

This was found to be highest amongst the responding countries in South-East Asia (90%) and lowest in the Americas (36%)

“Data from WHO’s Surveillance System for Attacks on Health Care indicate that between 1 January 2018 and 31 March 2025, there were more than 8,300 incidents of attacks reported from 22 countries/territories with over 3,000 deaths and over 6,000 injuries of health workers and patients,” according to the report.

The report recommends measures to support nurses and other health workers in post-conflict settings and reduce attrition including providing opportunities for professional development, incorporating financial incentives and allowing flexibility.

Image Credits: World Bank/Flickr, WHO, MSF/ Dr Obaid.

Nurses preparing rapid COVID-19 diagnostics in 2020. Post-pandemic, new and more affordable rapid tests for HIV and other infections remain a major R&D priority.

A Nigerian Health Tech firm, Codix Bio, has been awarded a license to develop and manufacture a new generation of rapid diagnostic tests (RDTs) royalty-free for African consumers, using technology transferred from a South Korean firm. The deal is a breakthrough for WHO’s new Health Technology Access Programme (HTAP) and the non-profit Medicines Patent Pool – which aim to facilitate tech transfer to the Global South post-COVID pandemic, when the dearth of local manufacturing left many countries short on medicines and diagnostics as well as vaccines.

Using innovative new technology supplied by South Korea’s SD Biosensor, Codix Bio will first develop and produce a new line of highly-sensitive rapid tests for HIV/AIDS, which can generate results within 20 minutes, WHO said in an announcement of the deal on Friday. But the technology can also be adapted to develop and manufacture tests for malaria and syphilis, among other diseases.

In December 2023, SDB signed a non-exclusive license with MPP to enable development and manufacture of new diagnostic tools using its cutting edge technology in low- and middle-income countries, in sharing arrangements brokered under the auspices of the WHO COVID-19 Technology Access Pool (C-TAP).

In January 2024, CTAP morphed into HTAP – with a mandate to stimulate innovation and facilitate access to new health technologies beyond COVID tools in underserved regions, by expanding local manufacturing capacity. Through HTAP, WHO and MPP issued an open call for applications by LMIC-based manufacturers to produce diagnostics using the SDB innovations, with Codix Bio selected as the first sublicensee.  According to the original SDB license with MPP, the tech transfer is royalty free for product sales in low- and middle-income countries.

The WHO announcement coincided with a gala launch of the partnership at the Codix Bio campus in Ogun State, near Lagos, with the participation of the Korean firm alongside their Nigerian counterparts.

“This landmark agreement is a defining moment in our journey of health-tech innovation and a breakthrough for local healthcare manufacturing in Africa. Being selected as the first sublicensee under this global initiative underscores our commitment to contribute meaningfully to pandemic preparedness and regional health security,” said Sammy Ogunjimi, CEO, Codix Group.

“With support from WHO and MPP, we are committed to producing high-quality, rapid diagnostic tests that can transform access to timely diagnosis, not just in Nigeria, but across the continent,” he said.

“The announcement of this sublicensing agreement with Codix Bio marks an important milestone in our partnership with WHO and MPP,” said Hyo-Keun Lee, Vice Chairman of SD Biosensor, Inc. “By coupling the technology transfer with coordinated support, this initiative not only helps Codix Bio respond to health priorities in Nigeria and the region – it also demonstrates a collaborative model for building sustainable and self-reliant local manufacturing capacity.”

Speaking from Geneva, Yukiko Nakatani, WHO Assistant Director-General, Access to Medicines and Health Products called the agreement “a major milestone in strengthening manufacturing capabilities in regions where they are needed most.

“It can help advance global commitments made at the 2023 World Health Assembly to promote equitable access to diagnostics as a cornerstone of universal health coverage and pandemic preparedness.”

Image Credits: University of Washington Northwest Hospital & Medical Center.

Nurses Appreciation Week in New York City, 2020; The applause at the height of the COVID pandemic has never been matched by improved working conditions, salaries or status.

With declining global spending on health, as the world prepares to observe International Nurses Day, Monday 12 May, there is renewed urgency to build health systems that respond to the needs of nurses and the people they serve. 

Investing in nurses yields high returns. It improves maternal and child health, HIV/AIDS prevention, and outbreak response for example, while strengthening primary healthcare systems. 

However, in many under-resourced settings throughout southern Africa health systems rest on the shoulders of an overwhelmed nursing workforce, who in addition to servicing high patient numbers in poorly equipped hospitals and clinics are sometimes forced to operate from churches, schools and other non-traditional settings where they cannot access the tools they need to effectively deliver care. They are often poorly paid, overworked, prone to burnout and constrained by limited opportunities for professional growth, yet they continue to discharge their duties with commitment, delivering much-needed care and saving millions of lives.

Despite the critical role that nurses play in keeping our already overburdened health systems afloat, a sudden decline in global health funding now poses an additional threat to the future of healthcare in Africa, with devastating impacts on health workers and the wellbeing of the communities they serve. 

African countries brace for impacts of cuts 

Nurses| Cameroon
Student nurses prepare for the morning rounds at the Ndop District Hospital in Bamenda, Cameroon

As countries in the Global North roll back commitments to fund global health institutions and initiatives, African countries must brace for the impacts of these actions on health systems that are already under immense strain. They must also urgently address the need for robust and responsive health systems that safeguard the wellbeing of caregivers while ensuring uninterrupted access to care for those most in need.

When resources meant to sustain health systems dry up, it exacerbates health disparities and increases the burden on already fragile health systems. Nurses, the backbone of healthcare delivery, often bear the brunt of these constraints. For example, the deep funding cuts have not only impacted the livelihoods of frontline health workers—mainly nurses and midwives—they have also deprived remote and marginalised communities of access to essential healthcare. 

Additionally, the cuts have disrupted nurse-led health programs focusing on maternal health, HIV/AIDS, TB, leprosy, and other infectious diseases in many vulnerable countries across Africa, collapsing essential health care services, impacting the quality of care and cutting an already limited health workforce.

Nurses need to be decision-makers as well as implementers  

Most healthcare is delivered by women- but systems continue to be led by men.

The WHO predicts a global shortage of 10 million nurses by 2030. Nurses need to be at the heart of global transformation as essential leaders and contributors to the design of healthcare policies, strategic decision-making, and effective implementation at all levels. However, in many countries, nurses are excluded from decision making and health system design. They—especially female nurses—are often seen as implementers rather than strategic thinkers, despite their experience of being on the frontlines and navigating challenging circumstances including disease outbreaks and shortages of essential medical goods. 

It is a fact that while women lead caregiving functions, they are excluded from leadership and hold only a fraction of senior decision-making roles globally, with even fewer of these roles being held by female nurses. Studies have shown that the under-representation of women in senior roles limits the development and implementation of equitable policies.

Building resilient health systems

An Ebola nurse prepares a sanitation solution in the DR Congo, September 2019.

The solution lies in building resilient health systems that are deliberate in meeting the needs of both providers and patients. Commitments to policy reforms for ensuring protection from workplace hazards and fair remuneration for overtime and high-risk duties should be prioritised. The ambitious, transformative goals of UHC become more achievable when we create clear pathways for nurses to work in environments that enable them to grow further into leadership roles. This also means increased investments in mentorship, training and structural support systems that empower nurses to lead and influence change. Academic institutions and training organisations must embed leadership and governance skills into nursing education, while the public and private sectors collaborate with professional nursing associations to co-create lasting solutions to the systemic barriers that prevent nurses from moving up the ladder.

Applause and praise are not enough

Frontlines of care: Nurses at the pharmacy of Layoune refugee camp regional hospital, Algeria, dispense prescription medicines to Sahrawi refugees.

For far too long, nurses have stood on the frontlines of care, keeping clinics running, tending to the needs of their communities, and holding together fragile health systems. They have done so tirelessly, often without adequate recognition, resources, or influence over the decisions that directly impact their daily work and the patients they serve. Applause, while appreciated, will not resolve chronic understaffing. Gratitude cannot cover living expenses or student debt. And praise alone will not promote nurses into the leadership roles most are qualified to hold.

To build robust, inclusive and responsive health systems, governments, the private sector and partners must come together in a unified effort to prioritize building a nursing workforce that is well supported and fit to propel Africa forward in its journey to achieving global health goals.

Akhona-Tshangela

 Akhona Tshangela is the WomenLift Health Southern Africa Director and a public health professional with over 15 years of service.  She has successfully implemented and led programs at both national and continental levels, demonstrating expertise in dealing with complex public health issues and contextualising these to the African continent.

Felistas-Mpachika-Mfipa

Felistas Mpachika-Mfipa is the Chief Reproductive Health Officer for the Reproductive Health Directorate, Malawi. With over 15 years’ experience, she has worked as a nurse practitioner and manager, maternal and neonatal health program manager, and researcher.

 

Image Credits: Raisa Santos , R Santos, © Dominic Chavez/The Global Financing Facility, ICN/Women in Global Health, WHO AFRO, European Union – Louiza Ammi.

US conservative Christian group Family Watch International president Sharon Slater (centre) meets with Uganda’s first lady, Janet Museveni, and other government officials in April 2023 to encourage passage of a new anti-homosexuality law.

Women’s groups and human rights organisations have raised the alarm about an African anti-rights conference taking place this weekend in Uganda, followed by another next week in Nairobi, featuring prominent US conservatives, aimed at developing “an African charter on family sovereignty and values”. 

Previous conferences have been used to mobilise for anti-LGBTQ laws and promote restrictions on sexual and reproductive rights on the continent, critics say.

Similar “African family” conferences have tried to “strip women of their basic human rights and dignity and reinforce the dominance of men within our society using ‘family values’ as a vehicle”, notes Women’s ProBono Initiative (WPI), a Ugandan women’s rights group.

The Entebbe Inter-Parliamentary Forum opened on Friday (9 May). Since its inception three years ago, it has served as a conservative platform for ultra-conservative African Members of Parliament.

Hosted by Uganda’s president and parliament, the forum has mobilised for copycat anti-LGBTQ laws in Uganda and Ghana with prison terms for those who identify as lesbian, gay, transgender, and bisexual. Conservative Kenyan MPs are working on a similar law.

Other concerning examples of shared policies are the Kenyan government’s 2023 “family protection policy” which undermined no-fault divorce, instead forcing parties into mediation even in cases of domestic abuse, says WPI. This has since been replicated by Uganda.

The Entebbe conference aims to adopt a conservative African ‘Charter’.

Notorious ‘hate groups’

The Entebbe forum taking place over the weekend is co-sponsored by Family Watch Africa, the continental branch of the Arizona-based Family Watch International (FWI), an anti-choice, abstinence-only organisation, also designated as a ‘hate group’ by the Southern Poverty Law Center in the US for its anti-LGBTQ agenda. 

Family Watch International’s Sharon Slater is due to speak at both anti-rights conferences.

FWI president Sharon Slater, who is presenting the opening session, is notorious for championing anti-LGBTQ laws in Africa and organises annual “training sessions” for African politicians in Arizona on how to lobby for conservative causes at the United Nations and other multilateral forums.

“Whenever an anti-LGBTQ law is passed in Africa, you are assured Sharon Slater had a hand in it!” says Tabitha Saoyo Griffith, a human rights lawyer and Amnesty International Kenya board member.

Last year’s forum featured addresses by two of the continent’s most vociferous anti-vaxxers, Shabnam Mohamed and Wahome Ngare, who delivered blistering attacks on several life-saving vaccines, as reported by Health Policy Watch.

Mohamed heads the Africa chapter of Children’s Health Defense, the anti-vaccine group founded by Robert F Kennedy Jr, currently the US Secretary of Health and Human Services.  

Ngare is a director of the conservative lobby group, the Kenyan Christians’ Professionals Forum (KCPF). Nine Ugandan medical professional bodies issued a statement disavowing Wahome’s misinformation after his address. 

This year’s forum will not be public, and attendees have to agree to abide by “Chatham House rules” (no disclosure or attribution of information) when registering. 

“This is worrying because these elected representatives, discussing African family values, are accountable to the people who elected them. The secretive nature of these discussions points to a sinister plan that will result in harmful decisions with life-and-death consequences,” says Joy Asasira, a sexual and reproductive health rights advocate from Uganda.

From Entebbe to Nairobi

On Monday, May 12, a day after the Entebbe forum ends, the Pan-African Conference on Family Values convenes in Nairobi, Kenya. 

Co-hosted by anti-vaxx Ngare’s KCPF, this is an even bigger gathering than Entebbe. It aims at “promoting and protecting the sanctity of life, family values and religious freedom”, as well as equipping delegates “with tools to strengthen advocacy efforts at national, regional, and global levels,” according to pre-conference publicity. 

Ironically, its keynote speakers are predominantly white conservative men from the United States and Europe. US Secretary of State Marco Rubio had even been invited to speak, but cancelled his planned visit to Kenya – reportedly in protest against Kenyan President William Ruto’s recent visit to China.

There is a proliferation of white Western men as  keynote speakers for the Pan-African Conference on Family Values in Nairobi that starts on 12 March.

The cast of speakers includes Austin Ruse, the president of the ultra-conservative Center for the Family and Human Rights (C-Fam), who describes himself as “descended of colonists” and a “Knight of Malta”, a Catholic order.

Also due to speak are Family Watch International’s Slater; Dutch conservative lobbyist Henk Jan van Schothorst; and US anti-LGBTQ politicians Robert Destro, a deputy secretary of state under the first Trump administration, and former senator John Crane; as well as leaders of the ultra-conservative Polish group, Ordos Iuris. Kenya’s Labour Ministry is also supporting the conference.

Advisors to Trump’s ‘Project 2025’ co-sponsoring events

Two of the Nairobi conference co-sponsors – C-Fam and the Alliance Defending Freedom – were on the advisory committee of Project 2025, the conservative blueprint being followed by the US Trump administration which has led to life-threatening cuts to development aid in Africa. Meanwhile, another sponsor, FWI, has worked with the Heritage Foundation, which authored Project 2025.

Project 2025’s proposals to slash US Agency of International Development (USAID) grants, prioritise funding for faith-based organisations and prohibit funding for “sexual reproductive health and reproductive rights” and “gender equality” programmes have all been implemented.

“It is outrageous that these organisations have been given a platform, when they are part of an initiative that pushed for slashing aid that is harming Africa families, and undermining the health of children, women and men and vulnerable communities,” said Dr Haley McEwan, a research associate at the University of Witwatersrand’s Centre for Diversity Studies in South Africa.

“This conference is part of decades-long activities of US Christian right organisations in the region. The fact that it features high-profile government speakers shows that they are gaining influence and power and this is even more concerning, particularly in light of the damaging funding cuts.”

Three of the sponsors of the Pan-African Conference on Family Values in Nairobi served on the Project 2025 advisory committee that proposed the Trump administration slashes development aid.

“Why are these white American men so concerned about African families? Is this not another form of colonialism? ” asks Kemi Akinfaderin, chief global advocacy officer for Fòs Feminista, a global network of over 150 organisations working for sexual and reproductive rights.

“They are trying to instil fear by claiming that there is an agenda to reduce Africa’s fertility and population rates, but this is an imposition of Western problems, such as declining fertility rates, on Africa.” 

Human rights organizations petition against use of Red Cross-owned hotel 

Over 20 Kenyan human rights organisations, backed by more than 12,000 signatories, petitioned the Red Cross, the main shareholder of Nairobi’s Boma Hotel where next week’s conference is being held, to try to persuade them to refuse to host the gathering.

In their letter, the human rights organisations point to the KCPF’s opposition to laws aimed at curbing maternal mortality in Kenya and its involvement in promoting Uganda’s Anti-Homosexuality Act. The KCPF is also opposing access to contraception for people under the age of 18.

“By giving the conference a platform, Red Cross Kenya is endorsing discriminatory ideologies that contradict the Red Cross’s commitment to alleviating human suffering and prioritising the lives of the most vulnerable,” they wrote.

However, the Red Cross, a principal recipient of the Global Fund grants in Kenya, responded that it was not involved in the day-to-day running of the hotel.

Human rights organisations have also sponsored billboards on the road from Nairobi’s airport to the hotel, stating: “True family values bring everyone together – not tear us apart.”

Billboards on the road from Nairobi’s airport protest anti-rights conferences with messages calling for an inclusive definition of families.

Narrow Western definition of ‘family’

Akinfaderin notes that the anti-rights groups have a “Western-centric, Eurocentric definition” of the family centred on a man as the head of the family, which is “not aligned with the more expansive realities of African families”.

“According to these groups, women’s rights, LGBTQI rights, access to safe abortion and comprehensive sexuality education, are anti-family initiatives,” says Akinfaderin.

“Their justification is that, if more women and girls know their rights and having a sense of value and empowerment, it means that they’re less likely to want to stay home and bear children. But women’s and girls’ aspirations are greater than their reproductive capacities. They want to go to school, work, and earn their income. They want the right to decide for themselves: physical, economic, social, and bodily autonomy,” she adds.

Anti-LGBTQ legislation was introduced in Uganda and Ghana shortly after previous year’s conferences. Ghana’s former president did not sign his country’s bill into law but conservative MPs are planning to reintroduce it under the new government. 

There are fears that this month’s events will galvanise Kenyan MPs to do the same, particularly as the conference is supported by Kenya’s Department of Labour and President Ruto is an evangelical Christian with close ties to US conservatives.

Sierra Leone is debating a Safe Motherhood Bill that will allow access to abortion to reduce its high maternal mortality rate.

Meanwhile, Akinfaderin points to several other ‘family values’ conferences in the offing in Africa in the coming months, including the Strengthening Families Conference organised by the Church of Latterday Saints (Mormons) in June in Sierra Leone. FWI’s Slater is a Mormon.

Sierra Leone’s lawmakers are currently considering the Safe Motherhood Bill, which would allow abortion up to 12 weeks (24 weeks in cases of rape, incest or danger to the mother’s health) as a measure addressing the country’s currently high maternal mortality rate. An estimated 10% of maternal deaths are due to now illegal, unsafe abortions. Lobbying by religious anti-abortion groups has thwarted a 2016 initiative to decriminalise abortion in Sierra Leone.

“It’s no mistake that they’re targeting Sierra Leone,” says Akinfaderin.

Where are the pro-family initiatives?

If these organisations and conferences are really pro-family, why are they not promoting policies that support families to thrive, ask the women’s groups and activists?

“Families need food, water, housing, access to healthcare, and protection,” says Saoyo Griffith.

“They should be talking about policies that help individuals to be able to make informed decisions about having children,” says Akinfaderin. “Pro-family policies should be about expanding access to contraception and family planning, assisted reproductive techologies like in vitro fertilisation (IVF), child care services, parental leave, social protection, and ending sexual violence in the home.” 

Women are at the core of families and if MPs want to support families, they should fast-track laws that protect women, such as the East African Community Sexual and Reproductive Health Bill, and laws on sexual offences and policies to extend social protection to single parents, says WBI.

“Families should never be a place where women’s rights are stripped away or where women live as second-class citizens who only exist to serve men. Instead, families should be a place of liberation where women can thrive and live life to the fullest on their own terms,” adds WBI.

Image Credits: Africa News.